| Balance Sheets | 2025-09-30 | 2025-06-30 | ||
|---|---|---|---|---|
| Cash and cash equivalents | 2,813 | 410 | ||
| Accounts receivable-Nonrelated Party | 892 | - | ||
| Accounts receivable | - | 1,300 | ||
| Inventory, net | 6,552 | 6,996 | ||
| Due from related parties | - | 112 | ||
| Accounts receivable-Related Party | 271 | - | ||
| Prepaid expenses and other current assets | 1,060 | 825 | ||
| Total current assets | 11,588 | 9,643 | ||
| Property, plant and equipment, gross | 750 | - | ||
| Less accumulated depreciation | 581 | - | ||
| Property and equipment, net | 169 | 188 | ||
| Finance lease right-of-use assets, net | 144 | 154 | ||
| Operating lease right-of-use assets, net | 474 | 550 | ||
| Intangible assets, net | 531 | 553 | ||
| Goodwill | 615 | 615 | ||
| Total assets | 13,521 | 11,703 | ||
| Accounts payable | 3,120 | 6,370 | ||
| Current portion of finance lease liability | 64 | 63 | ||
| Current portion of operating lease liability | 372 | 366 | ||
| Loans from related parties | - | 6,810 | ||
| Loans from related parties-Related Party | 0 | - | ||
| Convertible notes payable, net | 0 | 14,752 | ||
| Derivative liability | 0 | 13,711 | ||
| Accrued interest | 0 | 1,371 | ||
| Other accrued liabilities | 1,817 | 2,193 | ||
| Total current liabilities | 5,373 | 45,636 | ||
| Finance lease liability, net of current portion | 44 | 61 | ||
| Operating lease liability, net of current portion | 136 | 234 | ||
| Total liabilities | 5,553 | 45,931 | ||
| Preferred stock, 0.0001 par value 30,000,000 shares authorized 18,406,857 series a-1 issued and outstanding as of june30, 2025 and december31, 2024 liquidation value 26,981 and 25,405 as of june30, 2025 and december31, 2024, respectively | - | 20,265 | ||
| Common stock, 0.0001 par value 150,000,000 shares authorized 73,701,176 and 9,286,235 shares issued as of september 30, 2025 and december 31, 2024, respectively of which 73,701,176 and 7,943,585 are outstanding as of september 30, 2025 and december 31, 2024, respectively | 7 | 1 | ||
| Additional paid-in capital | 80,283 | 7,370 | ||
| Accumulated other comprehensive income | 230 | 262 | ||
| Accumulated deficit | -72,552 | -62,126 | ||
| Stockholders equity (deficit) | 7,968 | -54,493 | ||
| Total liabilities, temporary equity, and stockholders equity (deficit) | 13,521 | 11,703 | ||
Picard Medical, Inc. (PMI)
Picard Medical, Inc. (PMI)